Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

John M Greally

Showing results (171-180 of 198) with videos related to

Pageof 20
Sort By:
The Journal of Clinical Investigation|February 1, 2019
Ascorbic acid-induced TET activation mitigates adverse hydroxymethylcytosine loss in renal cell carcinomaNiraj Shenoy, Tushar D Bhagat, John Cheville, et al.
The Journal of Biological Chemistry|May 3, 2011
Aberrant epigenetic and genetic marks are seen in myelodysplastic leukocytes and reveal Dock4 as a candidate pathogenic gene on chromosome 7qLi Zhou, Joanna Opalinska, Davendra Sohal, et al.
The Journal of Biological Chemistry|December 3, 2016
Notch Pathway Is Activated via Genetic and Epigenetic Alterations and Is a Therapeutic Target in Clear Cell Renal CancerTushar D Bhagat, Yiyu Zou, Shizheng Huang, et al.
American Journal of Medical Genetics. Part A|December 23, 2022
Detection of mosaic variants using genome sequencing in a large pediatric cohortJacqueline A Odgis, Katie M Gallagher, Atteeq U Rehman, et al.
Medrxiv : the Preprint Server for Health Sciences|July 18, 2023
The NYCKidSeq randomized controlled trial: Impact of GUÍA digitally enhanced genetic counseling in racially and ethnically diverse familiesSabrina A Suckiel, Nicole R Kelly, Jacqueline A Odgis, et al.
American Journal of Human Genetics|November 25, 2023
The NYCKidSeq randomized controlled trial: Impact of GUÍA digitally enhanced genetic results disclosure in diverse familiesSabrina A Suckiel, Nicole R Kelly, Jacqueline A Odgis, et al.
JCI Insight|July 27, 2018
The RUNX1/IL-34/CSF-1R axis is an autocrinally regulated modulator of resistance to BRAF-V600E inhibition in melanomaOrsi Giricz, Yongkai Mo, Kimberly B Dahlman, et al.
Genome Medicine|July 19, 2022
Recommendations for clinical interpretation of variants found in non-coding regions of the genomeJamie M Ellingford, Joo Wook Ahn, Richard D Bagnall, et al.
Plos Genetics|May 31, 2014
Mosaic epigenetic dysregulation of ectodermal cells in autism spectrum disorderEsther R Berko, Masako Suzuki, Faygel Beren, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics|May 9, 2023
Molecular diagnostic yield of genome sequencing versus targeted gene panel testing in racially and ethnically diverse pediatric patientsNoura S Abul-Husn, Priya N Marathe, Nicole R Kelly, et al.
Pageof 20

Showing results (171-180 of 198) with videos related to

Sort By:
Pageof 20
The Journal of Clinical Investigation|February 1, 2019
Ascorbic acid-induced TET activation mitigates adverse hydroxymethylcytosine loss in renal cell carcinomaNiraj Shenoy, Tushar D Bhagat, John Cheville, et al.
The Journal of Biological Chemistry|May 3, 2011
Aberrant epigenetic and genetic marks are seen in myelodysplastic leukocytes and reveal Dock4 as a candidate pathogenic gene on chromosome 7qLi Zhou, Joanna Opalinska, Davendra Sohal, et al.
The Journal of Biological Chemistry|December 3, 2016
Notch Pathway Is Activated via Genetic and Epigenetic Alterations and Is a Therapeutic Target in Clear Cell Renal CancerTushar D Bhagat, Yiyu Zou, Shizheng Huang, et al.
American Journal of Medical Genetics. Part A|December 23, 2022
Detection of mosaic variants using genome sequencing in a large pediatric cohortJacqueline A Odgis, Katie M Gallagher, Atteeq U Rehman, et al.
Medrxiv : the Preprint Server for Health Sciences|July 18, 2023
The NYCKidSeq randomized controlled trial: Impact of GUÍA digitally enhanced genetic counseling in racially and ethnically diverse familiesSabrina A Suckiel, Nicole R Kelly, Jacqueline A Odgis, et al.
American Journal of Human Genetics|November 25, 2023
The NYCKidSeq randomized controlled trial: Impact of GUÍA digitally enhanced genetic results disclosure in diverse familiesSabrina A Suckiel, Nicole R Kelly, Jacqueline A Odgis, et al.
JCI Insight|July 27, 2018
The RUNX1/IL-34/CSF-1R axis is an autocrinally regulated modulator of resistance to BRAF-V600E inhibition in melanomaOrsi Giricz, Yongkai Mo, Kimberly B Dahlman, et al.
Genome Medicine|July 19, 2022
Recommendations for clinical interpretation of variants found in non-coding regions of the genomeJamie M Ellingford, Joo Wook Ahn, Richard D Bagnall, et al.
Plos Genetics|May 31, 2014
Mosaic epigenetic dysregulation of ectodermal cells in autism spectrum disorderEsther R Berko, Masako Suzuki, Faygel Beren, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics|May 9, 2023
Molecular diagnostic yield of genome sequencing versus targeted gene panel testing in racially and ethnically diverse pediatric patientsNoura S Abul-Husn, Priya N Marathe, Nicole R Kelly, et al.
Pageof 20